CELC · Insider trading · 13F holders · Congress trades
Celcuity Inc. (CELC)
Who is buying and selling CELC: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 33
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 4
CELC at a glance
- No open-market insider purchases or sales of CELC were filed in the last 90 days.
- 33 13F filers hold CELC among their 50 largest positions, worth $2.9B combined, including Joseph Edelman, Julian and Felix Baker, Behzad Aghazadeh and James Flynn. The biggest bets by portfolio weight are Pfizer Inc (17.3%), NEA Management Company, LLC (11.3%) and Tang Capital Management LLC (6.3%). In their latest 13Fs, 3 managers opened a new position and 10 added to one.
- Members of Congress have disclosed 4 CELC trades since 2020, 3 purchases and 1 sale in the past year; the latest was Tom Malinowski (D-NJ), buying $1K–15K on Jun 23, 2020.
- CELC last closed at $68.32 on Oct 30, 2026.
CELC insider trading
No open-market insider purchases or sales of CELC were filed in the last 90 days.
Who owns CELC? Hedge funds and superinvestors
33 13F filers hold CELC among their 50 largest positions, worth $2.9B combined, including Joseph Edelman, Julian and Felix Baker, Behzad Aghazadeh and James Flynn. The biggest bets by portfolio weight are Pfizer Inc (17.3%), NEA Management Company, LLC (11.3%) and Tang Capital Management LLC (6.3%). In their latest 13Fs, 3 managers opened a new position and 10 added to one.
Superinvestors holding CELC: Joseph Edelman 5.2% · Julian and Felix Baker 4.2% · Behzad Aghazadeh 3.2% · James Flynn 1.9%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Julian and Felix BakerHedge fund | 4.2% | $828.2M | 7,915,792 | +0.0% shares | Q2 2026 |
| Behzad AghazadehHedge fund | 3.2% | $355.7M | 3,400,000 | +0.7% shares | Q2 2026 |
| Rtw Investments, LPHedge fund | 3.0% | $345.8M | 3,304,903 | +8.7% shares | Q2 2026 |
| Joseph EdelmanHedge fund | 5.2% | $334.5M | 3,197,200 | +2.2% shares | Q2 2026 |
| NEA Management Company, LLCHedge fund | 11.3% | $179.0M | 1,710,561 | -25.2% shares | Q2 2026 |
| Soleus Capital Management, L.P.Hedge fund | 6.1% | $178.3M | 1,704,318 | +32.7% shares | Q2 2026 |
| James FlynnHedge fund | 1.9% | $151.8M | 1,451,014 | -15.3% shares | Q2 2026 |
| Tang Capital Management LLCHedge fund | 6.3% | $137.5M | 1,314,594 | +25.2% shares | Q2 2026 |
| Apis Capital Advisors, LLCHedge fund | 5.5% | $56.3M | 538,000 | +4.5% shares | Q2 2026 |
| Silverarc Capital Management, LLCHedge fund | 5.8% | $52.4M | 500,996 | +40.0% shares | Q2 2026 |
| Boxer Capital Management, LLCHedge fund | 3.3% | $43.6M | 416,530 | +85.1% shares | Q2 2026 |
| Saturn V Capital Management LPHedge fund | 5.6% | $38.7M | 370,318 | +31.4% shares | Q2 2026 |
| First Turn Management, LLCInstitutional asset manager | 3.7% | $34.4M | 329,101 | +56.3% shares | Q2 2026 |
| Pfizer IncCorporation | 17.3% | $29.6M | 295,652 | +0.0% shares | Q2 2026 |
| Granahan Investment Management, LLCAsset manager | 0.7% | $18.7M | 179,053 | — | Q2 2026 |
| Caption Management, LLCHedge fund | 0.6% | $17.8M | 170,000 | — | Q2 2026 |
| Eversept Partners, LPHedge fund | 0.7% | $13.4M | 127,931 | — | Q2 2026 |
| Sio Capital Management, LLCHedge fund | 2.0% | $11.5M | 110,022 | -43.2% shares | Q2 2026 |
| Nan Fung Trinity (HK) LtdInvestment manager | 1.1% | $10.9M | 103,775 | +0.0% shares | Q2 2026 |
| Stempoint Capital LPHedge fund | 1.8% | $10.3M | 98,203 | +63.5% shares | Q2 2026 |
| Tetragon Partners GP LtdHedge fund | 1.1% | $6.7M | 64,110 | New | Q2 2026 |
| Act Capital Management, LLCHedge fund | 4.2% | $6.5M | 62,150 | -32.2% shares | Q2 2026 |
| Harvest Investment Services, LLCWealth manager | 1.0% | $6.3M | 59,747 | +9.8% shares | Q2 2026 |
| Artia Global Partners LPHedge fund | 1.2% | $6.2M | 59,316 | +280.8% shares | Q2 2026 |
| Gagnon Securities LLCWealth manager | 1.1% | $5.6M | 53,240 | -0.2% shares | Q2 2026 |
| Atom Investors LPHedge fund | 0.3% | $3.6M | 34,488 | -54.8% shares | Q2 2026 |
| Atle Fund Management ABAsset manager | 0.9% | $3.5M | 33,313 | -76.4% shares | Q2 2026 |
| Resolute Capital Asset Partners LLCHedge fund | 1.3% | $3.1M | 30,000 | New | Q2 2026 |
| Nan Fung Group Holdings LtdInvestment manager | 2.3% | $3.0M | 28,300 | +0.0% shares | Q2 2026 |
| Seven Fleet Capital Management LPHedge fund | 0.3% | $1.7M | 16,252 | — | Q2 2026 |
The 30 largest of 33 positions, by value. Each manager counts with its latest 13F (Q2 2026: 33). Screen CELC in the grand portfolio →
CELC stock trades by members of Congress
Members of Congress have disclosed 4 CELC trades since 2020, 3 purchases and 1 sale in the past year; the latest was Tom Malinowski (D-NJ), buying $1K–15K on Jun 23, 2020.
| Filed | Member | Trade | Amount | Traded | Since |
|---|---|---|---|---|---|
| Aug 26, 2021 | Tom MalinowskiD-NJ · House | Buy | $1K–15K | Jun 23, 2020 | +775.9% |
| Aug 26, 2021 | Tom MalinowskiD-NJ · House | Buy | $1K–15K | Jun 22, 2020 | +704.7% |
| Jun 23, 2021 | Tom MalinowskiD-NJ · House | Sale | $1K–15K | May 26, 2021 | +145.1% |
| Mar 5, 2021 | Tom MalinowskiD-NJ · House | Buy | $1K–15K | Jun 18, 2020 | +752.9% |
CELC questions and answers
Are insiders buying CELC stock?
No open-market insider purchases or sales of CELC were filed in the last 90 days.
Which hedge funds own CELC?
33 13F filers hold CELC among their 50 largest positions, worth $2.9B combined, including Joseph Edelman, Julian and Felix Baker, Behzad Aghazadeh and James Flynn. The biggest bets by portfolio weight are Pfizer Inc (17.3%), NEA Management Company, LLC (11.3%) and Tang Capital Management LLC (6.3%). In their latest 13Fs, 3 managers opened a new position and 10 added to one.
Has Congress traded CELC?
Members of Congress have disclosed 4 CELC trades since 2020, 3 purchases and 1 sale in the past year; the latest was Tom Malinowski (D-NJ), buying $1K–15K on Jun 23, 2020.
Who is the largest holder of CELC?
Among 13F filers, Julian and Felix Baker reports the largest CELC position, $828.2M (7,915,792 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Pfizer Inc's: 17.3% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.